These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7567114)

  • 1. [In vitro antibacterial activity of a new fluoroquinolone, enoxacin against hospital bacteria and regression curve].
    Soussy CJ; Cluzel M; Meyran M
    Pathol Biol (Paris); 1995 Apr; 43(4):274-80. PubMed ID: 7567114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro antibacterial activity of a new fluoroquinolone, fleroxacin, against hospital bacteria and regression curve].
    Soussy CJ; Cluzel M; Derlot E; Kitzis MD; Meyran M
    Pathol Biol (Paris); 1994 May; 42(5):385-92. PubMed ID: 7824301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro antibacterial activity of a new fluoroquinolone, temafloxacin, against hospital isolates. Results of a multicenter study].
    Soussy CJ; Morel C; Kitzis MD; Meyran M; Brun Y; Joly-Guillou ML; Dabernat H; Chanal M; Courtieu AL; Derlot E
    Pathol Biol (Paris); 1991 May; 39(5):403-9. PubMed ID: 1881670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro antibacterial activity of a new fluoroquinolone, sparfloxacin, against nosocomial bacteria, and concordance curve].
    Soussy CJ; Cluzel M; Derlot E; Exmelin L; Kitzis MD; Dabernat H; Le Noc P; Muller-Serieys C; Reverdy ME; Scheftel JM; Thabaut A
    Pathol Biol (Paris); 1996 Apr; 44(4):241-8. PubMed ID: 8763585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro antibacterial activity of lomefloxacin, a new fluoroquinolone, against hospital strains. Results of a multicenter study].
    Soussy CJ; Le Van Thoi J; Morel C; Acar JF; Thabaut A; Fleurette J; Vallée E; Dabernat H; Chanal M; Drugeon H
    Pathol Biol (Paris); 1990 May; 38(5):390-6. PubMed ID: 2195448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial activity of enoxacin in vitro and in urine].
    Soussy CJ; Deforges L; Duval J
    Pathol Biol (Paris); 1987 May; 35(5):475-81. PubMed ID: 3302849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro antibacterial activity of a new fluoroquinolone, fleroxacin as a function of the sensitivity or resistance to nalidixic acid and to pefloxacin].
    Soussy CJ; Leclercq R; Deforges L; Duval J
    Pathol Biol (Paris); 1989 May; 37(5):364-9. PubMed ID: 2506511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro effect of ceftriaxone on hospital bacteria. Line of regression and critical values].
    Cluzel M; Chanal M; Sirot D; Sirot J; Cluzel R
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):473-6. PubMed ID: 3937122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro antibacterial activity of apalcillin on aerobic bacteria and the regression curve].
    Soussy CJ; Duval J; Chanal M; Sirot D; Bergogne-Bérézin E; Joly-Guillou ML; Malbruny B; Morel C
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):660-4. PubMed ID: 3054743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study.
    Soussy CJ; Cluzel M; Ploy MC; Kitzis MD; Morel C; Bryskier A; Courvalin P
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():43-50. PubMed ID: 10404337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study].
    Soussy CJ; Deforges L; Le Van Thoi J; Chanal M; Sirot D; Acar JF; Kitzis MD; Thabaut A; Meyran M; Dabernat H
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):469-72. PubMed ID: 2868442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin].
    Aubert G; Puech C; Lucht F; Loboguerrero M; Denis M; Dorche G
    Pathol Biol (Paris); 1989 Oct; 37(8):881-7. PubMed ID: 2515519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status of resistance of bacteria to pefloxacin in hospital units. Cross resistance with ofloxacin and ciprofloxacin. Results of a multicenter study].
    Thabaut A; Meyran M; Fabre R; Dellamonica P; Moreau N
    Pathol Biol (Paris); 1994 May; 42(5):369-74. PubMed ID: 7824298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro antibacterial activity of clarithromycin, a new macrolide antibiotic, and regression curve].
    Soussy CJ; Le Van Thoi J; Cluzel M; Derlot E; Kitzis MD
    Pathol Biol (Paris); 1990 May; 38(5):401-6. PubMed ID: 2142274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].
    Soussy CJ; Otterbein G; Le Van Thoi J; Thabaut A; Meyran M; Courtieu AL; Reynaud A; Dabernat H; Lareng MB; Chanal M
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study.
    Soussy CJ; Nguyen J; Goldstein F; Dabernat H; Andremont A; Leclercq R; Drugeon H; Cavallo P; Chardon H; Etienne J; Rio Y; Courvalin P
    Clin Microbiol Infect; 2003 Oct; 9(10):997-1005. PubMed ID: 14616741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum bactericidal activity of 4 fluoroquinolones in healthy volunteers.
    Wang R; Liu YN; Zhao HZ; Sun XD
    Chin Med J (Engl); 1992 Jun; 105(6):500-5. PubMed ID: 1451552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.